Hypogonadism News

  • AbbVie Wins U.S. Trial in Lawsuit Over AndroGel's Risks A federal jury in Chicago on Friday found AbbVie Inc not liable in a lawsuit by an Arizona man who claimed he had suffered a pulmonary embolism due to using the company's testosterone replacement medication AndroGel.
  • FDA Panel Votes Down Oral Testosterone Replacement Products FDA advisers were primarily concerned about risk of cardiovascular side effects, which they felt could become a problem, particularly with off-label use of such products, which they believe is widespread

Hypogonadism Perspective

  • Testosterone Therapy and PCa Risk in Hypogonadal Men   Dr Chodak reviews a 'provocative' study on the risk for prostate cancer in men receiving testosterone therapy for hypogonadism.
  • CME: Can You Trust What You Read? A review of accredited educational programs on hypogonadism turned up some common themes, including those not supported by the evidence.